• Abbott received FDA approval for its Amplatzer Paraclose PVL Occluder to treat leaks around surgically replaced heart valves without repeat open-heart surgery.
• The device is the first U.S.-approved transcatheter treatment specifically designed for paravalvular leaks.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbott Laboratories published the original content used to generate this news brief on October 28, 2026, and is solely responsible for the information contained therein.